Stockholders' Equity |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Stockholders' Equity | |
| Stockholders' Equity | Note 13. Stockholders’ Equity The Company is authorized to issue up to 680,000,000 shares of common stock, without any par value per share. Each holder of common stock is entitled to one vote for each share held of record on all matters to be voted on by such holders. Holders of common stock are entitled to receive dividends, if declared. Upon liquidation, dissolution, or winding-up, holders of common stock are entitled to share ratably in the net assets legally available for distribution after payment of all debts and other liabilities, subject to any preferential rights of the holders of preferred stock, if any. During the six months ended June 30, 2026, the increase of approximately 6.4 million shares of common stock outstanding was attributable to the awarding of approximately 8.2 million restricted stock awards (“RSAs”) and the issuance of less than 0.1 million common shares in settlement of an equal number of fully vested restricted stock units (“RSUs”), net of approximately 0.2 million of shares with a fair value of approximately $2.5 million to cover taxes related to the settlement of such vested RSAs, as permitted by the 2019 Equity Incentive Plan, as amended (the “2019 Equity Incentive Plan”). These increases were partially offset by the forfeiture of approximately 1.6 million RSAs. Subsequent Stock-Based Compensation Activity During July 2026, approximately 16.5 million RSAs vested and the Company issued approximately 1.4 million common shares in settlement of an equal number of fully vested RSUs, net of approximately 4.1 million shares to cover taxes related to the settlement of such vested RSAs, as permitted by the 2019 Equity Incentive Plan. At-the-Market Equity (“ATM”) Program In December 2025, the Company established the 2025 ATM program, under which it could offer and sell up to $500.0 million in shares of the Company’s common stock (the “2025 ATM Program”). During the six months ended June 30, 2026, no shares were sold under the 2025 ATM Program, and as of June 30, 2026, all $500.0 million in shares of the Company’s common stock were available for sale under the 2025 ATM Program. |